AzTrials
AzTrials

Shoulder OsteoarthritisSIP_LaFeNCT06153381

Virtual Rehabilitation Assistant Via Instant Messaging Communication to Promote Adherence to Rehabilitation After Reverse Shoulder Replacement

A study testing Chatbot and Standard car in people with Shoulder Osteoarthritis, run by University of Valencia at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

reverse shoulder replacement surgery is performed to improve the functionality and reduce pain of the affected shoulder. Now, it is necessary to carry out an appropriate rehabilitation process to optimize surgical results. Read more about this study

Who is it for?
Any age
Conditions the study is for
Shoulder Osteoarthritis
What is being tested?
Chatbot and Standard car
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteSpain
Study dates
1 Sep 2023to 1 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients undergoing reverse shoulder replacement
  • With a personal smartphone
  • An instant messaging application installed
  • Familiar with the use of such an application (i.e., at least three accessess per week)
  • Able to write and read in the Spanish language

Who cannot join

  • Condition, whether cognitive, neurological, integrative or musculoskeletal, that obviously prevents understanding or performing the exercises of the rehabilitation program or may pose a risk to the patient's health.

Trial locations and contacts

1 site in 1 country.

Spain1 site, 1 recruiting
  • Hospital Universitario y Politécnico La Fe

    Valencia, Valencia, 46026

    Marta Navarro, MD, 961 24 40 00, mnb18504@gmail.com

    Recruiting

Other trials in Spain

About this study

Official title: Herramienta de Procesamiento de Lenguaje Natural en Dispositivo móvil Inteligente Para Asegurar la Adherencia a la rehabilitación Domiciliaria en cirugías de Artroplastia Invertida de Hombro (NLP-PTAdherence)

reverse shoulder replacement surgery is performed to improve the functionality and reduce pain of the affected shoulder. Now, it is necessary to carry out an appropriate rehabilitation process to optimize surgical results. The lack of health resources makes it essential for the patient to work autonomously once hospital rehabilitation is completed. But lack of adherence is one of the main barriers to recovery

Read the detailed description

The objective is to evaluate the effectiveness of a Chatbot that interacts with patients via instant messaging to supervise home rehabilitation and increase adherence. Conduct a feasibility study with a pilot sample

Being tested
Chatbot, Standard car

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ChatbotOther

    Rehabilitation program based on standard care, but assisted via an instant messaging application using a personal smartphone

  • Standard carOther

    Rehabilitation program based on standard care, assisted with one education session plus informative brochure

Study groups in NCT06153381
Study groupRoleWhat they receive
Chatbot careExperimentalNot described
Receives: Other: Chatbot; Other: Standard car
Standard careActive comparatorNot described
Receives: Other: Standard car

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Shoulder disability

    This is measured with the Quick Dash questionnaire, a self-reported survey of 11 items designed to assess symptoms and ability to perform certain activities. At least 10 items should be answered to calculate a score. Each answer can be scored from one to five, and the average value is calculated, thus obtaining a score from one to five. Then, to express the score in percentages, 1 is subtracted from the result and then multiplied by 25. The higher the score, the greater the disability.

    Measured: 0 weeks, 12 weeks

Secondary outcomes (4)
  1. Shoulder functionality

    measured with the Constant-Murley Score, a multi-item functional scale assessing pain, ADL, ROM and strength of the affected shoulder. Its score ranges from 0 to 100 points, representing worst and best shoulder function, respectively

    Measured: 0 weeks, 12 weeks

  2. Shoulder pain

    Assessed with a numeric pain rating scale, ranging from 0, the worst possible pain, to 10, no pain, with the question: What was your overall pain in the shoulder in the last week?

    Measured: 0 weeks, 12 weeks

  3. Quality of Life

    measured with the EQ-5D-5L quetionnaire, which essentially consists of 2 pages: the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The EQ VAS records the patient's self-rated health on a vertical visual analogue scale, where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'.

    Measured: 0 weeks, 12 weeks

  4. Number of sessions of rehabilitation completed

    Compliance with rehabilitation, measuring the number of sessions completed

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Dec 2023
  2. Study start1 Sep 2023
  3. Primary completion1 Jun 2024 (estimated)
  4. Study completion1 Jun 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06153381
Sponsor's protocol ID
SIP_LaFe
Acronym
SIP_LaFe
Status last verified
Dec 2023
First submitted
22 Nov 2023
Last updated
12 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Chatbot and Standard car in people with Shoulder Osteoarthritis, run by University of Valencia at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Shoulder disability (time frame: 0 weeks, 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in